Beyond PD-L1 IHC (TMB, Immune Microenvironment)

被引：0
|
作者：
Mino-Kenudsen, M. [1 ]
机构：
[1] Massachusetts Gen Hosp, Pathol, Boston, MA 02114 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
Tumor Mutation Burden; immune microenvironment; immune checkpoint inhibitor; BLOCKADE;
D O I：
10.1016/j.jtho.2019.08.216
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IBS08.02
引用
收藏
页码：S97 / S98
页数：2
相关论文
共 50 条
  • [41] The SP142 PD-L1 IHC assay for atezolizumab (atezo) reflects pre-existing immune status in NSCLC and correlates with PD-L1 mRNA
    Williams, J.
    Kowanetz, M.
    Koeppen, H.
    Boyd, Z.
    Kadel, E. E., III
    Smith, D.
    McCleland, M.
    Zou, W.
    Hegde, P. S.
    ANNALS OF ONCOLOGY, 2016, 27
  • [42] Regulation of PD-L1 expression in the tumor microenvironment
    Yi, Ming
    Niu, Mengke
    Xu, Linping
    Luo, Suxia
    Wu, Kongming
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2021, 14 (01)
  • [43] Regulation of PD-L1 expression in the tumor microenvironment
    Ming Yi
    Mengke Niu
    Linping Xu
    Suxia Luo
    Kongming Wu
    Journal of Hematology & Oncology, 14
  • [44] Correlation between PD-L1 expression/TMB and immune cell infiltration: A pan-cancer study
    Xiong, J.
    Xiang, X.
    Li, J.
    Huang, S.
    Chen, Y.
    ANNALS OF ONCOLOGY, 2020, 31 : S287 - S288
  • [45] Influence of PD-1/PD-L1 on immune microenvironment in oral leukoplakia and oral squamous cell carcinoma
    Xu, Shuang-Bo
    Wang, Meng-Yao
    Shi, Xin-Zhan
    Wang, Qiong
    Yu, Miao
    Zhang, Wei
    Xu, Xiao-Hui
    Liu, Lai-Kui
    ORAL DISEASES, 2023, 29 (08) : 3268 - 3277
  • [46] The immune microenvironment and expression of PD-L1, PD-1, PRAME and MHC I in salivary duct carcinoma
    Xu, Bin
    Jungbluth, Achim A.
    Frosina, Denise
    Alzumaili, Bayan
    Aleynick, Nathaniel
    Slodkowska, Elzbieta
    Higgins, Kevin
    Ho, Alan
    Morris, Luc
    Ghossein, Ronald
    Katabi, Nora
    HISTOPATHOLOGY, 2019, 75 (05) : 672 - 682
  • [47] PD-L1, TMB, MSI, and Other Predictors of Response to Immune Checkpoint Inhibitors in Biliary Tract Cancer
    Rizzo, Alessandro
    Ricci, Angela Dalia
    Brandi, Giovanni
    CANCERS, 2021, 13 (03) : 1 - 11
  • [48] Integration of Spatial PD-L1 Expression with the Tumor Immune Microenvironment Outperforms Standard PD-L1 Scoring in Outcome Prediction of Urothelial Cancer Patients
    Weyerer, Veronika
    Strissel, Pamela L.
    Strick, Reiner
    Sikic, Danijel
    Geppert, Carol I.
    Bertz, Simone
    Lange, Fabienne
    Taubert, Helge
    Wach, Sven
    Breyer, Johannes
    Bolenz, Christian
    Erben, Philipp
    Schmitz-Draeger, Bernd J.
    Wullich, Bernd
    Hartmann, Arndt
    Eckstein, Markus
    CANCERS, 2021, 13 (10)
  • [49] Immune checkpoint therapy: From CTLA-4 to PD-1/PD-L1 and beyond
    Sharma, Padmanee
    CANCER RESEARCH, 2018, 78 (13)
  • [50] Paired Comparison of PD-L1 Expression on Cytologic and Histologic Specimens From Malignancies in the Lung Assessed With PD-L1 IHC 28-8pharmDx and PD-L1 IHC 22C3pharmDx
    Skov, Birgit G.
    Skov, Torsten
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2017, 25 (07) : 453 - 459
12345